VelaLabs, your right choice for GMP compliant analytical characterization of biomolecules
|Jan 2018||Jennifer Mayrhofer appointed as Chief Project Manager (CPO)|
|Dec 2017||Revenues reach 4.7 million € (Export quote: 83%)|
|Dec 2017||In 2017, VelaLabs invested nearly 1,000,000 € to enhance its instrumental park|
|Feb 2017||Closing of Tentamus incorporation|
|Dec 2016||Revenues reach 4.0 million € (Export quote: 90%)|
|Dec 2016||DI (FH) Markus Roucka appointed as COO|
|Sep 2016||Celebration of 10 years VelaLabs|
|Jul 2016||AGES inspection and renewal of GMP certificate|
|May 2016||Acquisition of VelaLabs by Tentamus group|
|Aug 2015||Successful US FDA audit with focus on clinical development and bioanalytics|
|Jul 2014||EMA – first biosimilar batch release testing for the European market|
|Dec 2012||Vela sales reach 3 million € (Export quote: 88%)|
|May 2012||DI (FH) Klaus Hajszan appointed as Qualified Person|
|Oct 2011||Celebration: VelaLabs – 5 years on its way|
|Dec 2010||Vela sales reach 1.9 million € (Export quote: 79%)|
|Dec 2009||VelaLabs sales reach 1.0 million € (Export quote: 65%)|
|Dec 2008||VelaLabs sales reach 0.5 million € (Export quote: 55%)|
|Nov 2007||GMP certificate for VelaLabs by AGES/PharmMed Austria|
|Apr 2007||Lease contract for analytical laboratories, first customer acquired for analytical service business|
|Oct 2006||Founding of VelaLabs, appointment of Dr. Markus Fido as Managing Director (CEO)|
Team and Management
Markus Fido, Ph.D.
Chief Executive Officer
Managing Director / Founder
Besides serving as a Managing Director, Markus has also taken responsibilities as Head of Regulatory Affairs within the Quality Operations team. Additionally, he is in charge of business development items and client relations topics.
He was previously Head Quality Control at Igeneon/Aphton Biopharma where he was responsible for all QC aspects of pre-clinical and clinical projects such as stability studies, specifications, method validation, and product release. Before that, he was Group Leader of Immunology and Product Development at Biomin GmbH, Head Biochemical Control at Baxter AG and Head Quality Operations at Octapharma GmbH. He has more than 20 years of experience in pharmaceutical industry, with focus in vaccines, recombinant proteins and immune therapeutics. He has profound expertise in regulatory aspects such as third party audits, inspections and GMP guidelines. He has a management consulting education and additionally owns a doctorate in chemistry/biochemistry from the Technical University of Graz, Austria.
Klaus Hajszan, DI (FH)
Head Quality Assurance / Qualified Person
Klaus Hajszan is the responsible Qualified Person (QP) for VelaLabs and in addition holds the position of Head Quality.
He joined VelaLabs serving firstly as Senior Technician QC and Head Quality Control. He has more than 10 years of experience in the medical field and biotechnology industry. His experience includes protein analytics, quality control, quality assurance, and a profound knowledge of protein development (characterization, (pre)clinical studies). Furthermore, he is lector on international conferences (GMP, analytics, and method transfer).
Markus Roucka DI (FH)
Markus Roucka is responsible for Business Development and Marketing (CBDM).
He started his career at Biomin GmbH in R&D (fermentation optimization and QC in microbiology). During his studies at the University of Applied Sciences for medical and pharmaceutical biotechnology (IMC Krems) he searched at the UMCG Groningen. At VelaLabs he started as Senior Technician and further as Head of Laboratory for many years. He has more than 10 years of work experience in biotechnology industry including protein characterization under GMP regulations (biosimilars, biopharmaceuticals, biologics) with a focus on assay development and optimization. His main experience is within cell culture, flow cytometry and SPR (Biacore) methods.
Jennifer Mayrhofer MSc. MA
Jennifer Mayrhofer is the Chief Project Officer (CPO) of VelaLabs.
Jennifer Mayrhofer got a MSc. degree from the Technikum Vienna and a MA degree for project management and organizatio) from the FH of the BFI Vienna. After 4 years of research at the Medical University of Vienna she joined VelaLabs in 2011. Starting as laboratoty technician, her career at VelaLabs recently led to her appointment as Chief Project Officer (CPO).
We are constantly offering new job opportunities. Please send your application and CV to
Brunner Strasse 69/3
1230 Vienna, Austria
or per mail to jobs(at)vela-labs.at